GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 165 filers reported holding GOSSAMER BIO INC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $38,299 | -40.8% | 30,396 | +2.0% | 0.00% | – |
| Q4 2022 | $64,646 | -81.9% | 29,791 | -0.4% | 0.00% | -100.0% |
| Q3 2022 | $358,000 | +44.9% | 29,899 | +1.4% | 0.00% | +50.0% |
| Q2 2022 | $247,000 | -7.8% | 29,478 | -4.5% | 0.00% | +100.0% |
| Q1 2022 | $268,000 | -28.3% | 30,870 | -6.6% | 0.00% | -50.0% |
| Q4 2021 | $374,000 | -12.6% | 33,043 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $428,000 | +51.2% | 34,032 | -2.3% | 0.00% | +100.0% |
| Q2 2021 | $283,000 | -7.2% | 34,840 | +5.5% | 0.00% | 0.0% |
| Q1 2021 | $305,000 | -4.1% | 33,023 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $318,000 | -24.5% | 32,936 | -2.8% | 0.00% | -50.0% |
| Q3 2020 | $421,000 | +6.9% | 33,881 | +11.8% | 0.00% | 0.0% |
| Q2 2020 | $394,000 | +52.7% | 30,318 | +19.4% | 0.00% | +100.0% |
| Q1 2020 | $258,000 | -38.6% | 25,385 | -5.5% | 0.00% | -50.0% |
| Q4 2019 | $420,000 | -7.7% | 26,854 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $455,000 | +61.3% | 27,079 | +112.9% | 0.00% | +100.0% |
| Q2 2019 | $282,000 | +84.3% | 12,721 | +79.7% | 0.00% | 0.0% |
| Q1 2019 | $153,000 | – | 7,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
| Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
| Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
| Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
| Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
| HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
| Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
| Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
| ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
| EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |